Form 4 filings across 5 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 13 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 27 most recent Form 4 transactions.
| Jun 15 | TRAX | First Tracks Biotherapeuti… | MEXER◆ | 1,300 | — | — | — | Open the original filing on SEC.gov |
| Jun 15 | TRAX | First Tracks Biotherapeuti… | MEXER◆ | 6,030 | — | — | — | Open the original filing on SEC.gov |
| Jun 15 | TRAX | First Tracks Biotherapeuti… | MEXER | 7,330 | — | — | +61.8% | Open the original filing on SEC.gov |
| Jun 2 | AVTX | Avalo Therapeutics, Inc. | AGRANT◆ | 20,100 | — | — | — | Open the original filing on SEC.gov |
| May 12 | TRAX | First Tracks Biotherapeuti… | AGRANT◆↺ | 7,000 | — | — | — | Open the original filing on SEC.gov |
| May 12 | TRAX | First Tracks Biotherapeuti… | AGRANT◆↺ | 2,500 | — | — | — | Open the original filing on SEC.gov |
| Apr 20 | TRAX | First Tracks Biotherapeuti… | AGRANT◆ | 4,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 20 | TRAX | First Tracks Biotherapeuti… | AGRANT◆ | 6,030 | — | — | — | Open the original filing on SEC.gov |
| Apr 20 | TRAX | First Tracks Biotherapeuti… | AGRANT◆ | 1,300 | — | — | — | Open the original filing on SEC.gov |
| Apr 20 | TRAX | First Tracks Biotherapeuti… | AGRANT◆ | 5,500 | — | — | — | Open the original filing on SEC.gov |
| Apr 20 | TRAX | First Tracks Biotherapeuti… | AGRANT◆ | 16,510 | — | — | — | Open the original filing on SEC.gov |
| Apr 20 | TRAX | First Tracks Biotherapeuti… | AGRANT◆ | 16,510 | — | — | — | Open the original filing on SEC.gov |
| Apr 20 | TRAX | First Tracks Biotherapeuti… | AGRANT◆ | 8,015 | — | — | — | Open the original filing on SEC.gov |
| Apr 20 | TRAX | First Tracks Biotherapeuti… | AGRANT◆ | 10,600 | — | — | — | Open the original filing on SEC.gov |
| Mar 31 | AVTX | Avalo Therapeutics, Inc. | AGRANT◆ | 1,339 | $12.13 | $16.2K | — | Open the original filing on SEC.gov |
| Jan 6 | ANAB | Anaptysbio, INC | AGRANT◆ | 4,000 | — | — | — | Open the original filing on SEC.gov |
| Jan 6 | ANAB | Anaptysbio, INC | AGRANT◆ | 5,500 | — | — | — | Open the original filing on SEC.gov |
| Jan 5 | SABS | SAB Biotherapeutics, Inc. | AGRANT◆ | 240,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 31, 2025 | AVTX | Avalo Therapeutics, Inc. | AGRANT◆ | 1,043 | $14.74 | $15.4K | — | Open the original filing on SEC.gov |
| Sep 30, 2025 | AVTX | Avalo Therapeutics, Inc. | AGRANT◆ | 1,572 | — | — | — | Open the original filing on SEC.gov |
| Jun 17, 2025 | AVTX | Avalo Therapeutics, Inc. | AGRANT◆ | 40,200 | — | — | — | Open the original filing on SEC.gov |
| Jun 15, 2025 | ANAB | Anaptysbio, INC | MEXER◆ | 6,030 | — | — | — | Open the original filing on SEC.gov |
| Jun 15, 2025 | ANAB | Anaptysbio, INC | MEXER◆ | 1,300 | — | — | — | Open the original filing on SEC.gov |
| Jun 15, 2025 | ANAB | Anaptysbio, INC | MEXER | 7,330 | — | — | +161.7% | Open the original filing on SEC.gov |
| Jun 5, 2025 | CLDX | Celldex Therapeutics, Inc. | AGRANT◆ | 16,500 | — | — | — | Open the original filing on SEC.gov |